The purpose of article series from AdLib, ‘Product | People | Potential’ is to feature and showcase the very best UK start-ups with great potential, truly inspiring businesses that are shaking up their sector. We capture and share the stories behind the name. We...
News
Securing Early-Stage Funding for Retinal Innovations – ASRS Retina Times Summer 20212 Publication with contribution from CEO Michael O’Rourke
In the first 2 articles of the Retina Times Innovation and Entrepreneurship section, we discussed how to secure your intellectual property (IP), define your business model, assemble your team, and develop a quality management system (QMS). Here, we discuss fund...
Sophie Bakri MD, Chair of the Department of Ophthalmology at Mayo Clinic, Rochester, MN joins Re-Vana Scientific Advisory Board
Sophie Bakri MD, Chair of the Department of Ophthalmology at Mayo Clinic, Rochester, MN joins Re-Vana Scientific Advisory Board
Re-Vana Therapeutics Strengthens Executive Team with the Appointments of Michael Nash as Chief Commercial Officer and David Shima, PhD, as Vice President of R&D
New Appointments Bring Extensive Ocular Drug Delivery, Strategy and Scientific Expertise to Advance the Sustained Release of Biologics and Small Molecules into the Eye to Treat Sight-Threatening Eye Diseases Belfast, Northern Ireland – 23 February 2021 – Re-Vana...
ExSight Ventures discuss why they invested into Re-Vana
In the OIS Podcast, ExSight Ventures discuss why they invested into Re-Vana. Here is the segment where they discuss Re-Vana Therapeutics: Download the excerpt using this link.Listen to the Full Podcast Here (Discussion of Re-Vana commences at 43 minutes.)...